Home » Topics » Regulatory » Patents

Patents
RSS

Allergan presents novel agents for ocular disorders

Feb. 2, 2012

Galderma Pharma prepares new agent for rosacea

Feb. 2, 2012

Novel platinum(IV) complexes disclosed by Universidad Autonoma de Madrid

Feb. 2, 2012

New claudin-6-binding antibodies patented in Germany

Feb. 2, 2012

Korean scientists prepare novel compounds with muscle relaxant activity

Feb. 1, 2012

New treatment for rosacea designed by Galderma Pharma

Feb. 1, 2012

Novel DNA-dependent protein kinase inhibitors claimed by Merck KGaA

Feb. 1, 2012

Gilead Sciences discloses new agents for HIV infection

Feb. 1, 2012

Researchers at Gilead Sciences prepare novel sodium channel blockers

Feb. 1, 2012

Roche prepares new HCV NS5B inhibitors

Feb. 1, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...